Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125798151 | 12579815 | 1 | I | 201607 | 20160718 | 20160721 | 20160721 | EXP | FR-PFIZER INC-2016349290 | PFIZER | 62.00 | YR | F | Y | 0.00000 | 20160721 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125798151 | 12579815 | 1 | PS | TOVIAZ | FESOTERODINE FUMARATE | 1 | Oral | UNK | Y | 22030 | PROLONGED-RELEASE TABLET | ||||||||
| 125798151 | 12579815 | 2 | SS | LEVODOPA | LEVODOPA | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125798151 | 12579815 | 1 | Pollakiuria |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125798151 | 12579815 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125798151 | 12579815 | Akinesia | |
| 125798151 | 12579815 | Condition aggravated | |
| 125798151 | 12579815 | Parkinson's disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125798151 | 12579815 | 1 | 20160601 | 20160701 | 0 |